Discrepancies between Patients' Preferences and Educational Programs on Oral Anticoagulant Therapy: A Survey in Community Pharmacies and Hospital Consultations

PloS One
Diane Macquart de TerlineMarie Antignac

Abstract

Oral anticoagulation therapy is increasingly used for the prevention and treatment of thromboembolic complications in various clinical situations. Nowadays, education programs for patients treated with anticoagulants constitute an integrated component of their management. However, such programs are usually based on the healthcare providers' perceptions of what patients should know, rather than on patients' preferences. To investigate patients' viewpoints on educational needs and preferred modalities of information delivery. We conducted an observational study based on a self-administered questionnaire. To explore several profiles of patients, the study was designed for enrolling patients in two settings: during outpatient consultations in a cardiology department (Saint Antoine Hospital, Paris, France) and in community pharmacies throughout France. Of the 371 patients who completed the questionnaire, 187 (50.4%) were recruited during an outpatient consultation and 184 (49.6%) were recruited in community pharmacies. 84.1% of patients were receiving a vitamin K antagonist and 15.6% a direct oral anticoagulant. Patients ranked 16 of 21 (76.2%) questionnaire items on information about their treatment as important or essential; infor...Continue Reading

References

Jun 27, 1991·The New England Journal of Medicine·J Hirsh
May 18, 1999·Seminars in Thrombosis and Hemostasis·W G Breukink-Engbers
Mar 19, 2003·Patient Education and Counseling·Eric W BobergAndrew Salner
Feb 5, 2004·Journal of Thrombosis and Thrombolysis·Edith A Nutescu
Nov 7, 2006·Patient Education and Counseling·Linda C ZandbeltHanneke C J M de Haes
Apr 12, 2007·BMC Public Health·Hege K AndreassenRolf Wynn
Jul 11, 2007·Archives of Internal Medicine·Diane K WysowskiLynette Swartz
Feb 16, 2008·BMC Health Services Research·James L WoffordSonal Singh
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Jan 22, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·L WintzR Gagnayre
Feb 2, 2010·Enfermería clínica·Josep M García-Alamino, Rafael Perera
Mar 6, 2010·Patient Education and Counseling·Gary L Kreps, Linda Neuhauser
Apr 16, 2010·The Cochrane Database of Systematic Reviews·Josep M Garcia-AlaminoCarl J Heneghan
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Nov 4, 2011·Gynecologic Oncology·Janet PapadakosSarah E Ferguson
Nov 25, 2011·The New England Journal of Medicine·Daniel S BudnitzChesley L Richards
Dec 6, 2011·Lancet·Paul Alexander Kyrle, Sabine Eichinger
Oct 13, 2012·Patient Education and Counseling·Robin K MatsuyamaMaureen C Wilson-Genderson
Jan 3, 2013·Journal of Thrombosis and Haemostasis : JTH·P Y H WongA Holbrook
Feb 9, 2013·Patient Education and Counseling·Sebastian KohlmannKarl-Heinz Schulz
Oct 30, 2013·JAMA : the Journal of the American Medical Association·Victor M MontoriM Hassan Murad

❮ Previous
Next ❯

Citations

Jan 3, 2021·International Journal of Clinical Pharmacy·Sophie KhettarAudrey Janoly-Dumenil

❮ Previous
Next ❯

Software Mentioned

R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.